EV/EBITDA
-13.42
+0.04+0.30%
Wed, 12 Mar 2025 23:08:39 GMT
Summary
- As of March 13, 2025, MYGN EV/EBITDA is -13.42, with a rise of +0.04 (+0.30%) during the most recent trading day.
- Over the past year, MYGN EV/EBITDA has dropped by -2.02 (-17.72%).
- MYGN EV/EBITDA is now -105.08% below its all-time high of 263.95.
Performance
MYGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MYGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.3% | -0.3% | -0.3% |
| 1 m1 month | +16.1% | -16.1% | -16.6% |
| 3 m3 months | +27.6% | -27.6% | -28.6% |
| 6 m6 months | +71.3% | -59.2% | -60.3% |
| ytdytd | +22.8% | -22.8% | -23.5% |
| 1 y1 year | -17.7% | -49.9% | -51.4% |
| 5 y5 years | -154.6% | -13.4% | -16.4% |
MYGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.0% | -18.94 | +29.1% | |
| 3 m | 3-month | -12.20 | -10.0% | -18.94 | +29.1% |
| 6 m | 6-month | -12.20 | -10.0% | -50.68 | +73.5% |
| 1 y | 1-year | -9.61 | -39.6% | -50.68 | +73.5% |
| 3 y | 3-year | 263.95 | -105.1% | -50.68 | +73.5% |
| 5 y | 5-year | 263.95 | -105.1% | -81.32 | +83.5% |
| alltime | all time | 263.95 | -105.1% | -455.85 | +97.1% |
Myriad Genetics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -13.42(-22.8%) |
| 2024 | -17.38(+111.2%) |
| 2023 | -8.23(-44.9%) |
| 2022 | -14.95(-109.0%) |
| 2021 | 166.09(-1720.4%) |
| 2020 | -10.25(-121.4%) |
| 2019 | 47.95(+122.7%) |
| 2018 | 21.53(+52.6%) |
| 2017 | 14.11(+40.1%) |
| 2016 | 10.07(-36.1%) |
| 2015 | 15.75(+27.0%) |
| 2014 | 12.40(+150.5%) |
| 2013 | 4.95(-52.4%) |
| 2012 | 10.39(+12.2%) |
| 2011 | 9.26(-29.3%) |
| Date | Value |
|---|---|
| 2010 | 13.09(-24.1%) |
| 2009 | 17.24(-18.2%) |
| 2008 | 21.08(-136.3%) |
| 2007 | -58.09(+12.2%) |
| 2006 | -51.77(+143.5%) |
| 2005 | -21.26(+26.5%) |
| 2004 | -16.80(+58.2%) |
| 2003 | -10.62(-27.3%) |
| 2002 | -14.60(-88.5%) |
| 2001 | -126.74(-33.7%) |
| 2000 | -191.26(+226.7%) |
| 1999 | -58.54(+723.3%) |
| 1998 | -7.11(-75.1%) |
| 1997 | -28.60(+61.8%) |
| 1996 | -17.68(-95.8%) |
| 1995 | -418.46 |
FAQ
- What is Myriad Genetics EV/EBITDA?
- What is the all time high EV/EBITDA for Myriad Genetics?
- What is MYGN EV/EBITDA year-to-date change?
- What is Myriad Genetics EV/EBITDA year-on-year change?
What is Myriad Genetics EV/EBITDA?
The current EV/EBITDA of MYGN is -13.42
What is the all time high EV/EBITDA for Myriad Genetics?
Myriad Genetics all-time high EV/EBITDA is 263.95
What is MYGN EV/EBITDA year-to-date change?
Myriad Genetics EV/EBITDA has changed by +3.96 (+22.78%) since the beginning of the year
What is Myriad Genetics EV/EBITDA year-on-year change?
Over the past year, MYGN EV/EBITDA has changed by -2.02 (-17.72%)